投資評等
最後更新日期：2024/12/26
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/9/11 | Howard Weil | Sector Perform >> Sector Outperform | $240 >> $280 |
| 2013/4/16 | Canaccord Genuity | Sell >> Hold | |
| 2012/7/2 | Barclays | Equal Weight >> Overweight | $122 >> $104 |
| 2012/6/18 | UBS | Neutral >> Buy | $118 >> $118 |
| 2011/7/8 | Stifel Nicolaus | Hold >> Buy | 110 |
| 2011/3/29 | Barclays Capital | Equal Weight >> Overweight | $103 >> $119 |
| 2010/9/7 | FBR Capital | Mkt Perform >> Outperform | 85 |
| 2010/6/4 | Stifel Nicolaus | Hold >> Buy | 80 |
| 2010/2/4 | BMO Capital Markets | Market Perform >> Outperform | $50 >> $55 |
| 2009/8/18 | Oppenheimer | Perform >> Outperform | 35 |
| 2009/6/16 | BMO Capital Markets | Underperform >> Market Perform | |
| 2006/11/2 | Credit Suisse | Underperform Neutral | |
| 2005/2/15 | Smith Barney Citigroup | Hold->Buy | |
| 2004/10/5 | Harris Nesbitt | Neutral->Outperform | 41 |
| 2004/5/5 | RBC Capital Mkts | Sector Perform->Outperform | 37 |
| 2004/5/5 | Wachovia | Mkt Perform->Outperform | |
| 2004/4/26 | Goldman Sachs | In-Line->Outperform | |
| 2004/3/2 | Banc of America Sec | Neutral->Buy | |
| 2003/12/18 | CSFB | Neutral->Outperform | |
| 2003/1/15 | First Albany | Buy -> Strong Buy | 35 |
| 2002/7/26 | Merrill Lynch | NT Buy -> NT Strong Buy | 27 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/6/17 | Global Hunter Securities | Buy >> Accumulate | $220 >> $260 |
| 2013/9/17 | Howard Weil | Sector Outperform >> Sector Perform | 195 |
| 2012/11/2 | Canaccord Genuity | Buy >> Hold | $115 >> $111 |
| 2011/11/11 | Deutsche Bank | Buy >> Hold | $89 >> $100 |
| 2011/1/27 | Stifel Nicolaus | Buy >> Hold | |
| 2010/6/25 | Caris & Company | Above Average >> Average | $69 >> $69 |
| 2010/2/26 | Stifel Nicolaus | Buy >> Hold | |
| 2010/2/19 | Credit Suisse | Outperform >> Neutral | $44 >> $47 |
| 2009/5/11 | UBS | Buy Neutral | |
| 2009/5/8 | FBR Capital Markets | Outperform Mkt Perform | |
| 2009/2/11 | Oppenheimer | Outperform Perform | |
| 2009/2/5 | Oppenheimer | Outperform Perform | |
| 2006/4/3 | Morgan Stanley | Equal-weight Underweight | |
| 2005/7/7 | Harris Nesbitt | Outperform->Neutral | |
| 2005/5/4 | JP Morgan | Overweight->Neutral | |
| 2004/12/9 | Lehman Brothers | Equal-weight->Underweight | |
| 2004/10/20 | Banc of America Sec | Buy->Neutral | |
| 2004/5/6 | Merrill Lynch | Buy->Neutral | |
| 2004/5/5 | CSFB | Outperform->Neutral | $40 |
| 2004/3/30 | Wachovia | Outperform->Mkt Perform | |
| 2003/12/22 | Southwest Securities | Strong Buy->Neutral | |
| 2003/12/18 | Prudential | Overweight->Neutral | $30 |
| 2002/9/16 | Lehman Brothers | Overweight -> Equal-weight | 28 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2014/10/10 | Imperial Capital | Outperform | 270 |
| 2013/9/13 | Wunderlich | Buy | 197 |
| 2012/11/21 | Deutsche Bank | Buy | |
| 2010/10/6 | KeyBanc Capital Mkts | Buy | 90 |
| 2010/9/29 | MKM Partners | Buy | 88 |
| 2010/4/22 | Susquehanna Financial | Neutral | |
| 2010/2/11 | C.K. Cooper | Buy | 58 |
| 2009/10/16 | Caris & Company | Above Average | 45 |
| 2006/9/20 | Wachovia | Mkt Perform | |
| 2005/10/18 | CSFB | Neutral | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2015/4/9 | Stifel | Buy | 195 |
| 2009/11/17 | Howard Weil | Market Outperform | 54 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2014/12/11 | Deutsche Bank | Hold | $219 >> $208 |
| 2014/11/5 | Topeka Capital Markets | Hold | $215 >> $200 |
| 2014/10/13 | Topeka Capital Markets | Hold | $230 >> $215 |
| 2014/3/18 | Deutsche Bank | Hold | $201 >> $208 |
| 2012/2/9 | Barclays Capital | Equal Weight | $101 >> $111 |
| 2011/11/30 | Barclays Capital | Equal Weight | $93 >> $107 |
| 2011/8/10 | Barclays Capital | Overweight | $113 >> $93 |
| 2011/4/8 | RBC Capital Mkts | Outperform | $117 >> $124 |
| 2011/2/11 | Oppenheimer | Outperform | $96 >> $110 |
| 2011/2/8 | UBS | Neutral | $95 >> $100 |